β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
Recent nutritional epidemiological surveys showed that serum β-cryptoxanthin inversely associates with the risks for insulin resistance and liver dysfunction. Consumption of β-cryptoxanthin possibly prevents nonalcoholic steatohepatitis (NASH), which is suggested to be caused by insulin resistance a...
Saved in:
Main Authors: | Masuko Kobori, Yinhua Ni, Yumiko Takahashi, Natsumi Watanabe, Minoru Sugiura, Kazunori Ogawa, Mayumi Nagashimada, Shuichi Kaneko, Shigehiro Naito, Tsuguhito Ota |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/835e2199ff0e45d095e3c7ba0807db45 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between Equol Production Status and Nonalcoholic Steatohepatitis
by: Takemi Akahane, et al.
Published: (2021) -
Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
by: Tae Hyung Kim, et al.
Published: (2021) -
The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
by: D. H. Ipsen, et al.
Published: (2021) -
Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
by: Kawanaka M, et al.
Published: (2013) -
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
by: Alia Hadefi, et al.
Published: (2021)